Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

DON'T BUY

Company is a tough investment to make. Struggling to recover from mistakes made 10 years ago. Trying to earn return in negative interest rate environment for policy holders + shareholders is difficult.

DON'T BUY

MFC vs. SLF SLF is head and shoulders above MFC. SLF's model price is $78.85 (11% upside), nice yield of 3.2%, seems to be functioning. MFC, on the other hand, has been the same price for the last 15 years.

TOP PICK

Believes stock is very cheap. Not sensitive to market moves. Capital ratios and other major metrics improved, yet still cheap stock. Business is a solid, boring business.

STRONG BUY

Raised dividend by 18%. Growing business in NA and China. 80% of business is based on fixed income. If we see rising rates, will definitely benefit. Attractive proposition right now. Seasonally also tends to do well at this time. Yield is over 5%.

WEAK BUY

Why is this undervalued given its positive metrics? The answer is MFC's exposure to China, one of the worst-performing asset classes this year, which is surprising given the lack of Covid cases. Lifecos historically are a very good way to play rising interest rates. That could be another factor to like MFC.

BUY

Trades at a discount. Asia has powered much of its growth. No problems owning it in a rising interest rate environment. He's looking at EPS in the $4 range over the next couple of years, and a dividend of 5.5%. Starting to be more generous in dividends.

HOLD

MFC vs. SLF Both struggling. Have to invest in fixed income at low rates. Both problems growing business. MFC has struggled more with its international expansion. Neither is a great longer term grower. He'd choose MFC because of the dividend. If you sell one, pay attention to the tax hit. Yield is 4.6%, safe. SLF yield is around 3%.

PAST TOP PICK

(A Top Pick Dec 02/20, Up 8%) Double digit dividend increase. Perennially cheap, in stark contrast to its earnings growth rate. Good footprint in Canada, US, and Asia. Sees good upside, continues to buy.

BUY

Manulife vs. Canadian Tire as a dividend play He nearly made MFC a top pick today. He'd certainly buy. They just hiked their dividend and in the US they offloaded a lot of long-term risk. He through the market would have been more positive about the latter. Pays a 5.5% dividend now. Catalysts are head driven by new managers. He prefers MFC over Canadian Tire which faces rising input costs, lots of competition and weaker management. That said, CT is a decent investment.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly We reiterate MFC, a Canadian based financial and wealth services provider, as a TOP PICK. It pays a strong dividend backed by a payout ratio of 33% of cash flow. It trades only 7x current earnings, compared to peers at 12x, and it is valued right near book value. We recommend trailing up the previously recommended stop (from $17) to $21 looking to achieve $30 -- over 29% upside. Yield 4.7% (Analysts’ price target is $30.00)

BUY

Insanely cheap. Under 8x earnings. Dividend yield 5%. Improved capital ratio dramatically. Lifecos benefit a bit more from rising rates, and they're all trying to reduce their sensitivity to rates by diversifying into wealth management.

PAST TOP PICK

(A Top Pick Dec 03/20, Up 13%) Interest rate sensitivity has been dialed down since the financial crisis, but it's still there. Especially likes the excellent wealth and asset business, as well as exposure to the Asian EM consumer. Undemanding valuation at 7-8x earnings, yield of about 4%. Major discount to banks and peers. Good upside and re-rating potential.

WEAK BUY

It has not been performing well in the last few months but is a stable trade going forward. He likes their exposure in Asia.

BUY

Has disappointed a lot of people for a while. The valuation is silly, trading at 6x whereas Sunlife is at 10x. There is still tail risk with variable annuities. Operationally, they are doing well with good growth in Asia. 9-10% EPS growth trading at 6.6x. Comfortable owning it. Thinks it will work at these levels.

COMMENT

They have grown a franchise in Asia, and there's more upside there in life insurance whereas North America is saturated. MFC has had historic issues in investing, which has kept him away. The accounting can be complex in this business. He owns no lifecos.

Showing 211 to 225 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)